Sonic

product on market Capsule Pro-Nutra Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin is supported by moderate evidence for improving lipid profiles and metabolic health. The proprietary SONIC(TM) Weight Loss Blend lacks specific ingredient transparency, resulting in limited evidence to support its efficacy for weight management. Overall, the product's evidence coverage is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Sonic
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

30 mg (150% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
SONIC(TM) WEIGHT LOSS Blend (Proprietary)
510 mg

Other Ingredients

Microcrystalline Cellulose Gelatin Magnesium Stearate Stearic Acid FD&C Blue No. 1 FD&C Green No. 4 FD&C Red No. 3 FD&C Red No. 40 FD&C Yellow No. 6 Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take one (1) serving (1 capsule) 20-30 minutes before training, or as directed by a qualified healthcare practitioner. On non-training days, take one (1) serving (1 capsule) for continued support of fat burning capacity.

Warnings & Precautions

THIS IS AN EXTREMELY HARDCORE FAT BURNER THAT MAY BE USED BY ONLY THOSE THAT HAVE FIRST RECEIVED PRIOR CONSENT FROM THEIR HEALTH PRACTITIONER.

Caffeine warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee. Do not consume caffeine, or combine with synephrine, including but not limited to coffee, tea, soda, and other dietary supplements or medications containing phenylephrine or caffeine. Too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat. Discontinue use if you experience dizziness, severe headache, rapid heartbeat or shortness of breath.

Do not use if you are pregnant, nursing or allergic or contraindicated to aspirin.

KEEP THIS PRODUCT AND ALL SUPPLEMENTS OUT OF THE REACH OF CHILDREN.

Niacin may cause temporary flushing, tingling, skin reddening, and sensations of heat, especially if taken on an empty stomach. This is a common reaction.

Do not use if you are pregnant, nursing or allergic or contraindicated to aspirin.

Discontinue use two weeks prior to surgery or if upset stomach occurs.

Please Do Not Take without prior consent of you physician.

Do not exceed recommended dose. Do not take for more than eight (8) consecutive weeks.

Warnings: Not intended for use by persons under the age 18.

Get the consent of of a licensed physician before using this product, especially if you are taking medication, have a medical condition, or thinking about becoming pregnant.

Please read entire label before use.

Formulation Notes

Caution: SONIC(TM) contains B vitamin niacin.

Caffeine warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

Additional Information

When combined with a proper exercise and nutrition regimen. Statements based on early-stage independent 3rd party in vivo and/or in vitro model scientific research data findings for individual ingredients.

(D-Mannoheptulose) HIGH ENERGY WEIGHT LOSS May Experience: ~Increased Energy ~Mental Focus

SUPER CONCENTRATED ONE PILL PER DAY DOSE!

Rev 01-001-SON001 10/13

Metadata

Product Details

UPC / SKU8 51330 00439 4
DSLD Entry Date2014-04-25
Product TypeOther Combinations
FormCapsule
DSLD ID31960
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.